I’ve been forced to ration my insulin or simply go without.
We must find a balance between innovation and affordability, and patients like me can’t wait any longer for change.
We must find a balance between innovation and affordability, and patients like me can’t wait any longer for change.
Without expensive biologic medications, my spine could fuse and leave me unable to walk by the time I’m out of school.
I could have died. I slipped into a diabetic coma just as my mother arrived to advocate for me.
Instead of enjoying my retirement and focusing on my health, I carry around the overwhelming burden of Imbruvica’s price.
A system that allows runaway drug prices like these places a burden not only on patients themselves, but on everyone in this country by way of the outsized financial responsibility paid by taxpayers.
My symptoms shouldn’t worsen just because a drug company wants to make a few extra dollars of profit off of my diagnosis.
By the time I was about to turn 19, I was almost out of insulin and I ended up in diabetic ketoacidosis –– a serious condition that can lead to death.
Between the high cost of insulin and other supplies, affording the necessary treatments to survive as a diabetic can be incredibly costly.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.